Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure–activity relationships, and translational perspectives
Aashik Malik; Md Arif Naseer; Mayank Yadav; Zulphikar Ali; Jai Parkash KadianShow moreShow less
1. Adarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh, IndiaShow moreShow less
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity
Jabril M. Abdali; Lama A. Alshabani; Alistair K. Brown; Amit Kumar; Sam Wilcocks; Ahmed Y. G. Alhejaili; Sanjida Y. Kalam; D. Fernando Estrada; Claire SimonsShow moreShow less
1. School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Cardiff, U.K.; 2. Pharmaceutical Sciences Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia; 3. Pharmaceutical Sciences Department, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 4. Bioscience Institute, University of Newcastle, Newcastle upon Tyne, U.K.; 5. Department of Biochemistry, Jacobs School of Medicine and Biomedical Science, University at Buffalo, Buffalo, U.S.A.; 6. London School of Hygiene & Tropical Medicine, London, U.K.; 7. Brunel University London, Uxbridge, U.K.Show moreShow less
From danger to resolution: targeting purinergic signaling in CNS diseases
Camille Degryse; Kirti Gupta; Luc Buée; Thierry Burnouf; David Blum; Ming-Li ChouShow moreShow less
1. Lille Neuroscience & Cognition (LilNCog), UMR-S1172, Inserm, University of Lille, CHU Lille, Lille, France; 2. International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 3. NeuroTMULille, University of Lille, Lille, France; 4. Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, Taiwan; 5. International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, Taiwan; 6. NeuroTMULille, Taipei Medical University, Taipei, TaiwanShow moreShow less
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation
Jeffrey Yang; Longqin HuShow moreShow less
1. Hansoh Bio, LLC, Rockville, USA; 2. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, USA; 3. Rutgers Cancer Institute, New Brunswick, USAShow moreShow less
Pantoprazole as a potential repurposed drug targeting the adenosinergic system in esophageal cancer
Adriana Simioni; Rafael D Weimer; Julia B de Souza; Isadora V Citrini; Julia A da Rosa; Kaline Cardoso; Maria E Delawi; Luis FSM Timmers; Fernanda B MorroneShow moreShow less
1. Laboratório de Farmacologia Aplicada, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre, Brasil; 2. Programa de Pós-graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre, Brasil; 3. Programa de Pós-graduação em Medicina e Ciências da Saúde, Escola de Medicina, PUCRS, Porto Alegre, Brasil; 4. Programa de Pós-graduação em Biotecnologia, Univates, Lajeado, Brasil; 5. Programa de Pós-graduação em Ciências Médicas, Univates, Lajeado, BrasilShow moreShow less
An updated review of enantioselective syntheses and biological actions of carbanucleosides
Sheila I. de Diego Saadia; Sergio H. Szajnman; Juan B. RodriguezShow moreShow less
1. Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina; 2. CONICET-Universidad de Buenos Aires, Unidad de Microanálisis y Métodos Físicos en Química Orgánica (UMYMFOR), Buenos Aires, ArgentinaShow moreShow less
FAQ
How long does MEDICINAL CHEMISTRY RESEARCH take to review a manuscript?
As of 2026-11-19, CrushSCI has 21 complete review records for MEDICINAL CHEMISTRY RESEARCH. The fastest paper went from submission to acceptance in 4 days (Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD), received 2026-08-08, accepted 2026-08-12); the slowest took 179 days. The average is 52.4 days and the median is 38 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
